Literature DB >> 3808611

Histological study of epikeratophakia tissue lenses for myopia removed from two patients.

K Tamaki, T Yamaguchi, M B McDonald, H E Kaufman.   

Abstract

Epikeratophakia tissue lenses for the correction of myopia were removed from two patients as a result of postoperative complications such as stromal folds, complaints of glare, and decreased visual acuity. Light and electron microscopic analysis showed protrusions in Bowman's membrane and the anterior stroma corresponding to corneal folds that had been observed clinically. The epithelial cells in these areas contained many vacuolations and a thickened basement membrane. Hemidesmosomes were decreased in number. The tissue lenses had been cut 1.5 mm larger in diameter than the trephined recipient bed into which they were placed. Excess tissue lens material in the central area may have been thrown into folds by mechanical pressure, resulting in the histological changes, clinical signs, and optical distortion that necessitated removal of these grafts. Recently, the surgical technique has been modified, in an attempt to eliminate this problem.

Entities:  

Mesh:

Year:  1986        PMID: 3808611     DOI: 10.1016/s0161-6420(86)33530-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Histopathological and immunohistochemical studies of lenticules after epikeratoplasty for keratoconus.

Authors:  H Nakamura; F Riley; H Sakai; W Rademaker; B Y J T Yue; D P Edward
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

2.  Viability of keratocytes in epikeratophakia lenticules.

Authors:  H C Cheng; W J Armitage; M I Yagoubi; D L Easty
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

3.  Epikeratophakia for aphakia, keratoconus, and myopia.

Authors:  B L Halliday
Journal:  Br J Ophthalmol       Date:  1990-02       Impact factor: 4.638

4.  Epikeratophakia: histopathological and cultural study.

Authors:  G M Cavallini; L Longanesi; A De Pol; E C Campos; R Guerra
Journal:  Int Ophthalmol       Date:  1992-03       Impact factor: 2.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.